Monoallelic and biallelic mutations in RELN underlie a graded series of neurodevelopmental disorders.
RELN
Reelin
autism
epilepsy
lissencephaly
Journal
Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537
Informations de publication
Date de publication:
14 09 2022
14 09 2022
Historique:
received:
03
02
2022
revised:
02
04
2022
accepted:
19
04
2022
pubmed:
1
7
2022
medline:
17
9
2022
entrez:
30
6
2022
Statut:
ppublish
Résumé
Reelin, a large extracellular protein, plays several critical roles in brain development and function. It is encoded by RELN, first identified as the gene disrupted in the reeler mouse, a classic neurological mutant exhibiting ataxia, tremors and a 'reeling' gait. In humans, biallelic variants in RELN have been associated with a recessive lissencephaly variant with cerebellar hypoplasia, which matches well with the homozygous mouse mutant that has abnormal cortical structure, small hippocampi and severe cerebellar hypoplasia. Despite the large size of the gene, only 11 individuals with RELN-related lissencephaly with cerebellar hypoplasia from six families have previously been reported. Heterozygous carriers in these families were briefly reported as unaffected, although putative loss-of-function variants are practically absent in the population (probability of loss of function intolerance = 1). Here we present data on seven individuals from four families with biallelic and 13 individuals from seven families with monoallelic (heterozygous) variants of RELN and frontotemporal or temporal-predominant lissencephaly variant. Some individuals with monoallelic variants have moderate frontotemporal lissencephaly, but with normal cerebellar structure and intellectual disability with severe behavioural dysfunction. However, one adult had abnormal MRI with normal intelligence and neurological profile. Thorough literature analysis supports a causal role for monoallelic RELN variants in four seemingly distinct phenotypes including frontotemporal lissencephaly, epilepsy, autism and probably schizophrenia. Notably, we observed a significantly higher proportion of loss-of-function variants in the biallelic compared to the monoallelic cohort, where the variant spectrum included missense and splice-site variants. We assessed the impact of two canonical splice-site variants observed as biallelic or monoallelic variants in individuals with moderately affected or normal cerebellum and demonstrated exon skipping causing in-frame loss of 46 or 52 amino acids in the central RELN domain. Previously reported functional studies demonstrated severe reduction in overall RELN secretion caused by heterozygous missense variants p.Cys539Arg and p.Arg3207Cys associated with lissencephaly suggesting a dominant-negative effect. We conclude that biallelic variants resulting in complete absence of RELN expression are associated with a consistent and severe phenotype that includes cerebellar hypoplasia. However, reduced expression of RELN remains sufficient to maintain nearly normal cerebellar structure. Monoallelic variants are associated with incomplete penetrance and variable expressivity even within the same family and may have dominant-negative effects. Reduced RELN secretion in heterozygous individuals affects only cortical structure whereas the cerebellum remains intact. Our data expand the spectrum of RELN-related neurodevelopmental disorders ranging from lethal brain malformations to adult phenotypes with normal brain imaging.
Identifiants
pubmed: 35769015
pii: 6621910
doi: 10.1093/brain/awac164
pmc: PMC9989350
doi:
Substances chimiques
Reelin Protein
0
RELN protein, human
EC 3.4.21.-
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3274-3287Subventions
Organisme : NINDS NIH HHS
ID : R01 NS098004
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS050375
Pays : United States
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Genet Med. 2018 Nov;20(11):1354-1364
pubmed: 29671837
Am J Med Genet B Neuropsychiatr Genet. 2010 Mar 5;153B(2):549-553
pubmed: 19691043
PLoS One. 2015 Nov 06;10(11):e0141782
pubmed: 26544041
J Neurochem. 2017 Jul;142(1):89-102
pubmed: 28419454
Sci Rep. 2016 Apr 13;6:24327
pubmed: 27071546
Am J Med Genet A. 2018 Dec;176(12):2808-2812
pubmed: 30144370
J Mol Neurosci. 2021 Apr;71(4):675-690
pubmed: 32889693
Nature. 2012 Apr 04;485(7397):242-5
pubmed: 22495311
Clin Genet. 2018 Mar;93(3):419-428
pubmed: 28755412
Genomics. 1997 Jun 15;42(3):479-82
pubmed: 9205121
Eur J Hum Genet. 2021 Jan;29(1):141-153
pubmed: 32860008
Nature. 2014 Feb 13;506(7487):179-84
pubmed: 24463507
Neurol Res. 2022 Mar;44(3):262-267
pubmed: 34569441
Epilepsy Behav Case Rep. 2018 Nov 01;11:39-42
pubmed: 30619712
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15718-23
pubmed: 9861036
Metab Brain Dis. 2015 Jun;30(3):687-94
pubmed: 25227173
J Dev Biol. 2020 Sep 18;8(3):
pubmed: 32962021
J Genet. 1951 Jan;50(2):192-201
pubmed: 24539699
Am J Hum Genet. 2015 Jun 4;96(6):992-1000
pubmed: 26046367
Hum Mutat. 2017 Feb;38(2):216-225
pubmed: 27864847
Behav Brain Res. 2017 Aug 14;332:110-119
pubmed: 28506622
Nat Med. 2015 Feb;21(2):185-91
pubmed: 25621899
Mol Psychiatry. 2017 Mar;22(3):430-440
pubmed: 27240532
Neurosci Res. 2002 Aug;43(4):381-8
pubmed: 12135781
Sci Rep. 2018 Aug 29;8(1):13046
pubmed: 30158644
Psychiatry Res. 2015 Dec 15;230(2):716-8
pubmed: 26384575
Nat Genet. 2000 Sep;26(1):93-6
pubmed: 10973257
Epileptic Disord. 2020 Aug 1;22(4):443-448
pubmed: 32723706
Hum Mol Genet. 2022 Mar 3;31(5):665-673
pubmed: 34508592
Science. 2003 Aug 1;301(5633):649-53
pubmed: 12893944
Hum Mol Genet. 1996 Jul;5(7):989-93
pubmed: 8817336
Mol Psychiatry. 2003 Oct;8(10):885-92
pubmed: 14515139
Am J Med Genet B Neuropsychiatr Genet. 2014 Mar;165B(2):192-200
pubmed: 24453138
Front Cell Neurosci. 2016 May 09;10:122
pubmed: 27242434
Brain Res Mol Brain Res. 2002 Sep 30;105(1-2):153-6
pubmed: 12399118
PLoS One. 2013 Sep 16;8(9):e74167
pubmed: 24066114
J Biochem. 2021 Jul 3;169(5):511-516
pubmed: 33566063
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Cereb Cortex. 2015 Jan;25(1):167-79
pubmed: 23968836
Eur J Hum Genet. 2016 Apr;24(4):611-4
pubmed: 26395554
Nat Genet. 1995 May;10(1):77-83
pubmed: 7647795
Am J Hum Genet. 2016 Nov 3;99(5):1117-1129
pubmed: 27773430
Curr Opin Neurobiol. 2021 Feb;66:135-143
pubmed: 33197872
Hum Mol Genet. 2013 Nov 15;22(22):4485-501
pubmed: 23813976
Alzheimer Dis Assoc Disord. 2015 Apr-Jun;29(2):169-72
pubmed: 24384746
J Neurosci. 2017 Jan 25;37(4):960-971
pubmed: 28123028
Nature. 2014 Nov 13;515(7526):209-15
pubmed: 25363760
Clin Genet. 2016 Dec;90(6):545-549
pubmed: 27000652
Am J Med Genet A. 2007 May 1;143A(9):939-44
pubmed: 17431900
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Hum Mutat. 2018 Oct;39(10):1372-1383
pubmed: 29969175
Neuroreport. 1999 Apr 26;10(6):1329-34
pubmed: 10363948
Eur J Neurosci. 2011 Feb;33(4):689-98
pubmed: 21226776
Epilepsy Behav. 2017 Mar;68:103-107
pubmed: 28142128
Brain Res. 1982 Jul;256(3):293-302
pubmed: 7104762
Nature. 2014 Nov 13;515(7526):216-21
pubmed: 25363768
Nature. 1995 Apr 20;374(6524):719-23
pubmed: 7715726
Int J Environ Res Public Health. 2020 Oct 30;17(21):
pubmed: 33143244
Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2859-63
pubmed: 1557392
Mov Disord. 2015 Mar;30(3):415-9
pubmed: 25648840
Hum Mol Genet. 2001 Apr 15;10(9):973-82
pubmed: 11392322
Am J Med Genet B Neuropsychiatr Genet. 2007 Jan 5;144B(1):58-63
pubmed: 16958033
J Pers Med. 2020 Dec 29;11(1):
pubmed: 33383702
Genome Med. 2021 Feb 22;13(1):31
pubmed: 33618777
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11050-4
pubmed: 7972007
Bioessays. 1998 Mar;20(3):235-44
pubmed: 9631651
Genome Med. 2015 Jul 10;7(1):68
pubmed: 26217397